Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARDX · against 1,216 other Healthcare companies
Ranked #141 of 1,217 · scores higher than 88% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including ARDX · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | ARDX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 16.8% | 6.1% | 74% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 75.9% | 5.8% | 95% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 129 | 1.8B USD | 89 | 52 | |
| 129 | 2.2B USD | 89 | 32 | |
| 129 | 13.8B USD | 89 | 54 | |
| 141 | 4.4B CNY (≈$618M) | 88 | 66 | |
| 141 | 782M USD | 88 | 35 | |
| 141 | 2.4B SGD (≈$1.8B) | 88 | 79 | |
| 141 | 23.7B INR (≈$284M) | 88 | 58 | |
| 141 | 106M EUR (≈$116M) | 88 | 46 | |
| 141 | 4.3B USD | 88 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score